Acute hypernatremia promotes anxiolysis and attenuates stress-induced activation of the hypothalamic-pituitary-adrenal axis in male mice

Physiology and Behavior

Volumn 136, Issue , 2014, Pages 91-96

  Smith, Justin A ^a   Wang, Lei ^a   Hiller, Helmut ^a   Taylor, Christopher T ^a   de Kloet, Annette D ^b   Krause, Eric G ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Anxiety; Corticotropin releasing hormone; Depression; Hypernatremia; Hypertension; Oxytocin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CRE RECOMBINASE; SODIUM; SODIUM CHLORIDE; CORT PROTEIN, HUMAN; NEUROPEPTIDE; PHOTOPROTEIN; RED FLUORESCENT PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE IDENTIFICATION; HYPERNATREMIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMEDIATE EARLY GENE; MALE; MOUSE; NONHUMAN; SODIUM BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ETIOLOGY; EXERCISE; GENE EXPRESSION REGULATION; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL STRESS; METABOLISM; PATHOLOGY; RADIOIMMUNOASSAY; THERAPY; TRANSGENIC MOUSE;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HYPERNATREMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUMINESCENT PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROPEPTIDES; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; RESTRAINT, PHYSICAL; SODIUM; SODIUM CHLORIDE; STRESS, PSYCHOLOGICAL;

EID: 84916927903     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.03.027     Document Type: Article

References (33)

1. Häfner S., Baumert J., Emeny R.T., Lacruz M.E., Bidlingmaier M., Reincke M., et al. Hypertension and depressed symptomatology: a cluster related to the activation of the renin-angiotensin-aldosterone system (RAAS). Findings from population based KORA F4 study. Psychoneuroendocrinology Oct 2013, 38:2065-2074.
2. Murck H., Held K., Ziegenbein M., Künzel H., Koch K., Steiger A. The renin-angiotensin-aldosterone system in patients with depression compared to controls-a sleep endocrine study. BMC Psychiatry Oct 2003, 3:15.
3. Grippo A.J., Francis J., Beltz T.G., Felder R.B., Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav Apr 2005, 84:697-706.
4. Niebylski A., Boccolini A., Bensi N., Binotti S., Hansen C., Yaciuk R., et al. Neuroendocrine changes and natriuresis in response to social stress in rats. Stress Health Aug 2012, 28:179-185.
5. Neumann I.D., Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 2012, 35(11):649-659.
6. Benarroch E.E. Oxytocin and vasopressin social neuropeptides with complex neuromodulatory functions. Neurology Apr 2013, 80:1521-1528.
7. Leshem M. Low dietary sodium is anxiogenic in rats. Physiol Behav Jul 2011, 103:453-458.
8. Krause E.G., de Kloet A.D., Flak J.N., Smeltzer M.D., Solomon M.B., Evanson N.K., et al. Hydration state controls stress responsiveness and social behavior. J Neurosci Apr 2011, 31:5470-5476.
9. Frazier C.J., Pati D., Hiller H., Nguyen D., Wang L., Smith J.A., et al. Acute hypernatremia exerts an inhibitory oxytocinergic tone that is associated with anxiolytic mood in male rats. Endocrinology Jul 2013, 154:2457-2467.
10. Hoffman G.E., Smith M.S., Verbalis J.G. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol Jul 1993, 14:173-213.
11. Ben-Barak Y., Russell J.T., Whitnall M.H., Ozato K., Gainer H. Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J Neurosci Jan 1985, 5:81-97.
12. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates, compact third edition 2008, 3rd ed.
13. Stricker E.M., Verbalis J.G. Interaction of osmotic and volume stimuli in regulation of neurohypophyseal secretion in rats. Am J Physiol Feb 1986, 250:R267-R275.
14. Krause E.G., Melhorn S.J., Davis J.F., Scott K.A., Ma L.Y., de Kloet A.D., et al. Angiotensin Type 1 receptors in the subfornical organ mediate the drinking and hypothalamic-pituitary-adrenal response to systemic isoproterenol. Endocrinology Dec 2008, 149:6416-6424.
15. Heilig C.W., Stromski M.E., Blumenfeld J.D., Lee J.P., Gullans S.R. Characterization of the major brain osmolytes that accumulate in salt-loaded rats. Am J Physiol Dec 1989, 257:F1108-F1116.
16. He F.J., Markandu N.D., MacGregor G.A. Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension. Hypertension Jul 2005, 46:66-70.
17. de Wardener H.E., He F.J., MacGregor G.A. Plasma sodium and hypertension. Kidney Int Dec 2004, 66:2454-2466.
18. Fang Z., Carlson S.H., Peng N., Wyss J.M. Circadian rhythm of plasma sodium is disrupted in spontaneously hypertensive rats fed a high-NaCl diet. Am J Physiol Regul Integr Comp Physiol Jun 2000, 278:R1490-R1495.
19. O'Donaughy T.L., Qi Y., Brooks V.L. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats. Hypertension Oct 2006, 48:658-663.
20. O'Donaughy T.L., Brooks V.L. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels. Hypertension Apr 2006, 47:680-685.
21. Ludwig M., Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci Feb 2006, 7:126-136.
22. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology Jul 1997, 138:2829-2834.
23. Windle R.J., Kershaw Y.M., Shanks N., Wood S.A., Lightman S.L., Ingram C.D. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci Mar 2004, 24:2974-2982.
24. Sharp F.R., Sagar S.M., Hicks K., Lowenstein D., Hisanaga K. c-Fos messenger-RNA, Fos, and Fos-related antigen induction by hypertonic saline and stress. J Neurosci Aug 1991, 11:2321-2331.
25. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci Feb 1997, 20:78-84.
26. Mak P., Broussard C., Vacy K., Broadbear J.H. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. J Psychopharmacol Apr 2012, 26:532-542.
27. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., et al. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron Feb 2012, 73:553-566.
28. Davis M., Rainnie D., Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci May 1994, 17:208-214.
29. Hattori T., Morris M., Alexander N., Sundberg D.K. Extracellular oxytocin in the paraventricular nucleus: hyperosmotic stimulation by in vivo microdialysis. Brain Res 1/1/1990, 506:169-171.
30. Calhoun D.A. Hypertension in blacks: socioeconomic stress and sympathetic nervous system activity. Am J Med Sci Nov 1992, 304:306-311.
31. Calhoun D.A., Oparil S. Racial differences in the pathogenesis of hypertension. Am J Med Sci Dec 1995, 310(Suppl. 1):S86-S90.
32. Barnes V., Schneider R., Alexander C., Staggers F. Stress, stress reduction, and hypertension in African Americans: an updated review. J Natl Med Assoc Jul 1997, 89:464-476.
33. Epstein D.E., Sherwood A., Smith P.J., Craighead L., Caccia C., Lin P.H., et al. Determinants and consequences of adherence to the dietary approaches to stop hypertension diet in African-American and white adults with high blood pressure: results from the ENCORE trial. J Acad Nutr Diet Nov 2012, 112:1763-1773.